Gilbert & Cook’s Blueprint Medicines BPMC Stock Holding History

Gilbert & Cook’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,441	Closed	-$569K	–	212
2025 Q2	$569K	Buy	4,441 +83	+2%	+$8.62K	0.08%	126
2025 Q1	$386K	Buy	4,358 +4	+0.1%	+$390	0.06%	153
2024 Q4	$380K	Sell	4,354 -17	-0.4%	-$1.56K	0.05%	156
2024 Q3	$404K	Sell	4,371 -95	-2%	-$9.44K	0.06%	154
2024 Q2	$481K	Sell	4,466 -459	-9%	-$45.9K	0.07%	132
2024 Q1	$467K	Buy	4,925 +79	+2%	+$6.78K	0.06%	149
2023 Q4	$447K	Buy	4,846 +380	+9%	+$24.6K	0.06%	152
2023 Q3	$224K	Buy	+4,466	New	+$239K	0.04%	203

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gilbert & Cook's BPMC Position: Q3 2025 in Review

Gilbert & Cook sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 4,441 shares — an estimated $569K sold.

Gilbert & Cook first reported a position in BPMC in Q3 2023 and held it in 8 quarters. The position peaked at $569K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Gilbert & Cook reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Gilbert & Cook sold 4,441 Blueprint Medicines shares in Q3 2025, an estimated $569K.
Gilbert & Cook first reported a position in Blueprint Medicines in Q3 2023 and held it in 8 quarters.
Gilbert & Cook's Blueprint Medicines position peaked at $569K in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Gilbert & Cook's 13F filing for Q3 2025, filed 12 Nov 2025.